Calvert International Equity Fund Class I
CWVIX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 1825 Connecticut Avenue Nw Washington DC United States of America 20009
- IPO Date
- Feb 26, 1999
- CIK
- 0000884110
- Website
- calvert.com
- Similar Companies
- Business
- Calvert International Equity Fund Class I (CWVIX) is an open-end mutual fund that seeks high total return consistent with reasonable risk through a concentrated portfolio of international equities from high- and improving-quality companies exhibiting sound management of financially material ESG factors; it primarily invests in large-cap growth stocks from developed markets outside the U.S. and Canada, with top holdings including ASML Holding NV, Nestle SA, Iberdrola SA, Siemens AG, and AstraZeneca PLC, benchmarked against the MSCI EAFE Index. The fund offers Class I shares with a net expense ratio of 0.89%, a minimum initial investment of $1 million, and a portfolio turnover of approximately 35%, focusing on sectors such as financial services, industrials, technology, healthcare, and consumer cyclical across regions including the Eurozone, United Kingdom, and Europe ex-Euro. Managed by Calvert Research and Management, a Washington, DC-based firm founded in 1976 and now part of Morgan Stanley Investment Management following Eaton Vance's 2019 acquisition of Calvert's assets, the fund operates globally with Class A inception in July 1992 and Class I inception in February 1999. Recent developments include sustained emphasis on ESG integration amid 2025 market volatility, with quarterly attribution analysis as of June 30, 2025, highlighting strong contributions from information technology and utilities selections despite underperformance in healthcare, alongside Calvert's ongoing proxy voting aligned with long-term sustainability goals and contributions to impact initiatives like the Cut Carbon Note. The fund maintains a responsible investment approach via the Calvert Principles, excluding certain high-impact but illiquid holdings representing under 0.03% of assets, and targets institutional investors seeking ESG-screened international exposure.